Corbus Pharmaceuticals Holdings, Inc. (CRBP) Discusses Clinical Data Update From Phase 1/2 Study of CRB-701 Presented at ASCO - Slideshow
Corbus Pharmaceuticals Holdings, Inc. recently presented an update on clinical data from its Phase 1/2 study of CRB-701 at the ASCO conference. The presentation included a slide deck detailing the findings of the study. This update is part of Corbus's ongoing efforts to advance its research and development initiatives.
- ▪Corbus Pharmaceuticals Holdings, Inc. discussed clinical data from its Phase 1/2 study of CRB-701.
- ▪The update was presented at the ASCO conference.
- ▪A slide deck was published in conjunction with the event.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4908830-corbus-pharmaceuticals-holdings-inc-crbp-discusses-clinical-data-update-from-phase-1-2-study"},"author":{"@type":"Person","name":"SA Transcripts","url":"https://seekingalpha.com/author/sa-transcripts"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New York","addressRegion":"NY","postalCode":"10001","addressCountry":"US"},"alternateName":["SeekingAlpha","SA"],"brand":[{"@type":"Brand","name":"Seeking Alpha Premium","url":"https://seekingalpha.com/subscriptions/premium"},{"@type":"Brand","name":"Seeking Alpha…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
